http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105055370-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28908f42a3efe1ea914a0ca680268028
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
filingDate 2015-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11a5e63913a29e394e6c79e84e7cb22e
publicationDate 2015-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105055370-A
titleOfInvention Antipyretic analgesic namely aspirin composition capsules
abstract The invention relates to an antipyretic analgesic namely aspirin composition capsules, and belongs to the technical field of medicines. The composition capsules are prepared from aspirin, starch, polyethylene oxidized azo ketone, magnesium carbonate, povidone K30, 95% ethanol and talc powder. The aspirin is a now-crystal-form compound, an X-ray powder diffraction pattern obtained by using Cu-Kalpha ray measurement is shown by a drawing 1, and the aspirin is different from the aspirin reported in the prior art; and a test discovers that the capsules prepared by using the aspirin novel-crystal-form compound are high in dissolvability and good in stability and are relatively low in content of free salicylic acid, and along with the increase of the storage time, the content of the free salicylic acid is not obviously increased, so that the adverse reaction of gastrointestinal tracts of the medicine is greatly reduced.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106822197-A
priorityDate 2015-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454463663
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454570538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21893751
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489556
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224

Total number of triples: 35.